Clinical Trial Detail

NCT ID NCT04009681
Title A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Synthorx, Inc.
Indications

Advanced Solid Tumor

Therapies

THOR-707 + unspecified PD-L1 antibody

THOR-707 + unspecified PD-1 antibody

THOR-707

THOR-707 + unspecified CTLA4 antibody

Age Groups: senior adult

No variant requirements are available.